Evaluation of the Bioequivalence of Sprinkle & Capsule Formulations of

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02361749` - Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation	Phase 4
Terminated	`NCT02239510` - Efficacy of Linaclotide to Senna for CIC	N/A
Completed	`NCT01895543` - Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation	Phase 3
Completed	`NCT01460225` - Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation	Phase 4
Completed	`NCT02291679` - Trial of Linaclotide in Patients With Chronic Idiopathic Constipation	Phase 3
Completed	`NCT01989234` - A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation	Phase 2
Completed	`NCT01993875` - Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation	Phase 3
Completed	`NCT01674530` - Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation	Phase 3
Completed	`NCT01429987` - The Plecanatide Chronic Idiopathic Constipation (CIC) Study	Phase 2/Phase 3
Completed	`NCT01982240` - 12-Week Study of Plecanatide for CIC (The CIC3 Study)	Phase 3
Completed	`NCT02590432` - An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation	Phase 4
Completed	`NCT02481947` - A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults	Phase 3
Completed	`NCT01372423` - Evaluation of Clinical Equivalence Between Two Lubiprostone Products	Phase 3
Completed	`NCT03054506` - The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation	N/A
Recruiting	`NCT04804267` - Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation	Phase 3
Completed	`NCT03879239` - Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation	N/A
Completed	`NCT01053962` - SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation	Phase 2
Completed	`NCT03551873` - A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®
Completed	`NCT02819297` - BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults	Phase 3
Completed	`NCT02819310` - An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults	Phase 3

NCT number	NCT03097861
Study type	Interventional
Source	Mallinckrodt
Contact
Status	Completed
Phase	Phase 3
Start date	March 13, 2017
Completion date	August 17, 2017

Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms